Peter Olagunju - 17 Nov 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role: Chief Technical Officer
Signature: /s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 17 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Nov 2022, 15:22:29 UTC
Previous filing: 10 Dec 2021
Next filing: 05 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TCRR	Common Stock						2,192	17 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRR	Stock Option (right to buy)	Disposed to Issuer	$0	-31,520	-100%	$0.000000^*	0	17 Nov 2022	Common Stock	31,520	$12.69	Direct	F1, F2
transaction	TCRR	Restricted Stock Unit (right to buy)	Award	$0	+10,507		$0.000000	10,507	17 Nov 2022	Common Stock	10,507		Direct	F2, F3, F4
transaction	TCRR	Stock Option (right to buy)	Disposed to Issuer	$0	-254,847	-100%	$0.000000^*	0	17 Nov 2022	Common Stock	254,847	$12.69	Direct	F1, F5
transaction	TCRR	Restricted Stock Unit (right to buy)	Award	$0	+84,949		$0.000000	84,949	17 Nov 2022	Common Stock	84,949		Direct	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This cancelled option vested 25% on July 26, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F2	On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 10,507.
F3	Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F4	35% of these RSUs will vest December 1, 2022, 25% of these RSUs will vest on each of December 1, 2023 and December 1, 2024, and the remaining 15% of RSUs will vest on December 1, 2025.
F5	On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 84,949.